| Title | Issues of women’s health throughout their lifespan | |
| Author | Maria Lavdaniti
Department of Nursing, Alexander Technological Educational Institution of Thessaloniki, Thessaloniki, Hellas |
|
| Citation | Lavdaniti, M.: Issues of women’s health throughout their lifespan, Epitheorese Klin. Farmakol. Farmakokinet. 23(3): 163-170 (2009) | |
| Publication Date | Accepted for publication (Final Version): July 1, 2009 | |
| Full Text Language | English | |
| Order – Buy | Ηλεκτρονική Μορφή: pdf (10 €) – Digital Type: pdf (10 €)
pharmakonpress[at]pharmakonpress[.]gr |
|
| Keywords | Women health, cancer, cardiovascular disease, musculoskeletal health, eating disorders. | |
| Other Terms | review article | |
| Summary | The position of women differs considerably from that of men with regard to illness, exposure to health risk factors and access to health services. This is due to not only to gender-specific biological differences but also to their different social roles. In Europe, women’s average life expectancy is over six years higher than men’s. The major causes of death vary with age, although there is evidence that the most frequent causes of death among women are disorders of the cardiovascular system and cancer. In health care and in international literature, women’s health traditionally stands for reproductive health and in particular their ability to produce children. Recently, studies worldwide have promoted an extended definition of women’s health that includes – but is not limited to – reproductive functions. Hence, women’s health is being redefined as encompassing their entire life span. In this paper, the most significant issues for women’s health will be described, including risk factors and treatment. Several health issues over recent decades have become knownby virtue of their relevance to or importance for women. These include eating disorders, which are most common in young women, HIV-infections, so far considered to be a predominantly male problem, as well as heart disease, also traditionally perceived to be a typically male disease, in spite of the significant mortality it causes in women. Furthermore, women’s greatest fear is cancer, particularly breast cancer, which causes so many deaths worldwide, although its incidence has decreased over the past years. Recently, other types of tumors have begun to afflict women, while a rapid increase of mortality from lung cancer among women has been recorded in the developed countries. In addition to these issues, muscular-skeletal health problems, and above all osteoporosis, should be added to the list of important women’s health issues. | |
| References | 1. The state of women’s health in the European Union: In Europa-Public Health-Overview of health policy available at http://ec.europa.eu/health/ph-overview (4/6/2009)
2. Writing Group of the 1996 AAAN Expert Panel on Women’s Health. Women’s Health and Women’s Health Care: Recommendations of the 1996, AAN Expert Panel on Women’s Health. Nurs. Outlook 45: 7-15 (1997) 3. Weisman C.S.: Changing Definitions of women’s Health: implications for Health care and Policy. Matern. Child Health J. 1: 179-189 (1997) 4. Kirschstein R.L.: Research on Women’s Health. Am. J. Public Health 81:291-293 (1991) 5. Dan A.J.: Integrated biomedical and feminist perspectives on women’s health. Women’s Health Issues 3: 101-103 (1993) 6. Society for Women’s Health Research: Health& Science: Health Facts available at http://www.womenshealthresearch.org (6/6/2009) 7. Polk D.M., Naovi T.Z.: Cardiovascular disease in women: sex difference in presentation, risk factors and evaluation. Curr. Cardiol. Rep. 7: 166-172 (2005) 8. American Heart Association. Diseases and Conditions available at http://www.americanhart.org (21/6/2009) 9. Mikhail G.W.: Coronary heart disease in women. BMJ 331: 467-468 (2005) 10. Mosca L., Manson J.E., Sutherland S.E., Langer R.D., Manolio T., Barrett-Connor E .: Cardiovascular disease in women. Circulation 96: 2468-2482 (1997) 11. Davis P.: Stroke in women. Curr. Opin. Neurol. 7: 36-40 (1994) 12. Stampfer M.J., Hu F.B., Manson J.E., Rimm E.B., Willett W.C. : Primary prevention of coronary heart disease in women through diet and lifestyle. N. Engl. J. Med. 343: 16-22 (2000) 13. Mieres J.H., Shaw L.J, Arai A., Budoff M.J., Flamm S.D., Hundley W.G., Marwick T.H., et al.: Role of noninvasive testing in the clinical evaluation of women with suspected coronary artery disease: consensus statement from the Cardiac Imaging committee, Council on Cardiovascular Radiology and Intervention, American Heart Association. Circulation 111: 682-696 (2005) 14. Savitz S.I., Schlaug G., Caplan L., Selim M.: Arterial occlusive lesions recanalize more frequently in women than in men after intravenous tissue plasminogen activator administration for acute stroke. Stroke 36: 1447-1451 (2005) 15. Belani C.P., Marts S., Schiller J., Socinski M.A.: Women and lung cancer: epidemiology, tumor biology, and emerging trends in clinical research. Lung Cancer 55: 15-23 (2007) 16. Pauk N., Kubik A., Zatioukal P., Krepela E.: Lung cancer in women. Lung Cancer 48: 1-9 (2005) 17. Radzikowska E, Glaz P., Roszkowski K.: Lung cancer in women: age, smoking, histology, performance status, stage, initial treatment and survival. Population-Based study of 20,561 cases. Ann. Oncol. 13: 1087-1093 (2002) 18. Baldini E.H., Strauss G.M.: Women and lung cancer: waiting to exhale. Chest 112: 229S-234S (1997) 19. Toyooka S., Tsuda T., Gazdar A.F.: The TP53 gene, tobacco exposure, and lung cancer. Hum. Mutat. 21: 229-239 (2003) 20. Nelson H.H., Christiani D.C., Mark E.J., Wience J.K., Wain J.C., Kelsey K.T.: implications and prognostic value of K-ras mutation for early-stage lung cancer in women. J. Natl. Cancer Inst. 91: 2032-2038 (1999) 21. Huber J.C., Schneeberger C., Tempfer C.B.: Genetic modelling of the estrogen receptor metabolism as a risk factor of hormone dependent disorders. Marititas 42: 1-12 (2002) 22. Siegfried J.M.: Women and lung cancer: does oestrogen play a role? Lancet Oncol. 2: 506-513 (2001) 23 American Cancer Society. Learn about cancer. Available at http://www.cancer.org (19/6/2009) 24. Lester J.: Breast cancer in 2007: incidence, Risk assessment, and risk reduction strategies. Clin. J. Oncol. Nurs. 11: 619-622 25. Jemal A., Siegel R., Ward E., Murray T., Xu J., Thun M.J.: Cancer Statistics 2007. CA Cancer J. Clin. 57: 43-66 (2007) 26. Mahoney M.C., Bevers T., Linos E., Willett W.C.: Opportunities and strategies for breast cancer prevention through risk reduction. CA Cancer J. Clin. 58: 347-371 (2008) 27. Deltsidou A. Epidemiology and risk factors of breast. Epitheorese Klinikes Farmakologias kai Farmakokinetikes 26: 187-191 (2008) (in Greek) 28. Deltsidou A.: Genetic Counselling for Hereditary Breast and Ovarian Cancer. Epitheorese Klinikes Farmakologias kai Farmakokinetikes 29: 283-292 (2009) (in Greek) 29. Deltsidou A.: Breast Self-Examination and Behavioral Models. Epitheorese Klinikes Farmakologias kai Farmakokinetikes 26: 193-201 (2008) (in Greek) 30. McLaughlin J.R., Risch H.A., Lubinski J., Moller P., Ghadirian P., Lynch H. et al.: Reproductive risk factors for ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case control study. Lancet Oncol. 8: 26-34 (2007) 31. Ramus S.J., Gayther S.A.: The contribution of BRCA1 and BRCA2. Mol. Oncol. 3: 138-150 (2009) 32. Basen–Enquist K., Paskett E.D., Buzaglo J., Miller S., Schover L., Wenzel L.B., Bodurka DC.: Cervical Cancer. Behavioral factors related to screening, diagnosis, and survivors ‘quality of life. Cancer 98: 2009-2014 (2003) 33. Wang K.L.: Human papillomavirus and vaccination in cervical cancer. Taiwan J. Obstet. Gynecol. 46: 352-362 (2007) 34. Teitelman A.M., Stringer M., Averbuch T., Witkoski A.: Human papillomavirus, current vaccines, and cervical cancer prevention. J. Obstet. Gynecol. Neonatal Nurs. 38: 69-80 (2009) 35. Fischer M.: Cancer of the cervix. Sem. Oncol. Nurs. 18: 193-199 (2002) 36. Janicek M.F., Averette H.E.: Cervical Cancer: Prevention, diagnosis, and therapeutics. CA Cancer J. Clin. 51: 92-114 (2001) 37. Porter S.: Endometrial cancer. Semin. Oncol. Nurs. 18: 200-206 (2002) 38. Heikinheimo O., Lahteenmaki P.: Contraception and HIV infection in women. Hum. Reprod. Update 15: 165-176 (2009) 39. HIV/AIDS among women. Available 6/6/2009 from http://www.cdc.gov/hiv/topics/women/resources/factsheets/women.htm 40. Jones J.L. Hanson D.L., Dworkin M.S., Alderton D.L., Fleming P.L., Kaplan J.E., Ward J.: Surveillance for AIDS –defining oppotunistic illnesses 1992-1997. MMWR CDC Surveill. Summ. 48: 1-22 (1999) 41. Phillips A.N. Antunes F., Stergious G., Ranki A., Jensen G.F., Bentwich Z., Sacks T., Pedersen C., Lundgren J.D., Johnson A.M.: A sex comparison of rates of new AIDS – defining disease and death in 2554 AIDS cases. AIDS in Europe Study Group. AIDS 8: 831-835 (1994) 42. DeWit S.C.: Medical–Surgical Nursing Concepts & Practice. Saunders-Elsevier 1: 321-329 (2009) 43. Murri R, Lepri A.C., Phillips A.N., Girardi E., Nasti G., Ferrara S., Et al : Access to antiretroviral treatment of sustained therapy interruptions, and risk of clinical events according to sex: evidence from the I.Co.N.A Study. J. Acquir. Immune Defic. Syndr. 34: 184-190 (2003) 44. Ofotokun I., Chuck S.K., Hitti J.E.: Antiretroviral pharmacokinetic profile: a review of sex differences. Gend. Med. 4: 106-109 (2007) 45. Peach C.A., Carr A.J., Loughlin J.: Recent advances in the genetic investigation of osteoarthritis. Trends Mol. Med. 11: 186-91 (2005) 46. Gokhal J.A., Frenkel S.R., Dicesare P.E.: Estrogen and osteoarthitis. Am. J. Orthop. 33: 71-80 (2004) 47. Lane N.E.: Epidemiology, etiology, and diagnosis of osteoporosis. Am. J. Obstet. Gynecol. 194: S3-11 (2006) 48. Keen R.: Osteoporosis: strategies for prevention and management. Best Pract. Res.Clin. Rheumatol. 21: 109-122 (2007) 49. Geusens P., Dinant G.: Integrating a Gender Dimension into Osteoporosis and Fracture Risk Research. Gend. Med. 4: 147-161 (2007) 50. Nazar B.P., Pinna C.M., Coutinho G., Segenreich D., Duchesne M., Appolinario J.C et al.: Review of literature of attention–deficit/hyperactivity disorder with comorbid eating disorder. Rev. Bras. Psiquitr. 30: 384-389 (2008) 51. Lozano G.A.: Obesity and sexually selected anorexia nervosa. Med. Hypotheses 71: 933-940 (2008). 52. Walsh J.M.E., Wheat M.E., Freud K.: Detection, Evaluation and treatment of eating disorders: the role of primary care physician. J. Gen. Intern. Med. 15: 577-590 (2000) 53. Deltsidou A.: Menstrual patterns in adolescents with eating disorders. Epitheorese Klinikes Farmakologias kai Farmakokinetikes 27: 155-162 (2009) (in Greek) 54. Fairburn C.G.: Evidence-Based treatment of anorexia nervosa. Int. J. Eat. Disord. 37: S26-30 (2005) |
|
| Relative Papers |
Online ISSN 1011-6575
Άρθρα Δημοσιευμένα σε αυτό το Περιοδικό Καταχωρούνται στα:
- Chemical Abstracts
- Elsevier’s Bibliographic Databases: Scopus, EMBASE, EMBiology, Elsevier BIOBASE SCImago Journal and Country Rank Factor
Articles published in this Journal are Indexed or Abstracted in: • Chemical Abstracts • Elsevier’s Bibliographic Databases: Scopus, EMBASE, EMBiology, Elsevier BIOBASE SCImago Journal and Country Rank Factor
Συντακτικη Επιτροπή-Editorial Board
| ΕΤΗΣΙΑ ΣΥΝΔΡΟΜΗ 2009 – ANNUAL SUBSCRIPTION 2009 | |
| Γλώσσα Πλήρους Κειμένου – Full Text Language | Αγγλικά – English |
| Παραγγελία – Αγορά – Order – Buy | Ηλεκτρονική Μορφή: pdf (70 €) – Digital Type: pdf (70 €)
pharmakonpress[at]pharmakonpress[.]gr |
| Έντυπη Μορφή (70 € + έξοδα αποστολής) – Printed Type (70 € + shipping)
pharmakonpress[at]pharmakonpress[.]gr |
|